Healthcare IT teams need MSP software that supports HIPAA obligations, protects PHI, and covers clinical workstations and shared devices without disrupting patient care. The products below are the closest fit for regulated healthcare environments.
No product in this category matches the healthcare IT filter yet, so all 15 are listed below.
All MSP software
Nothing in this category met the healthcare IT filter, so the full MSP software category is listed here instead.
The defining commercial characteristic is per-technician pricing with no endpoint cap: growing MSPs and internal IT teams that would otherwise pay per device see the saving as machine counts rise. Full RMM, PSA and remote access sit in a single cloud interface, so smaller shops end up running fewer separate systems day to day.
Monitoring, patching, remote access and backup arrive under one agreement here, which is the comparison SMB and mid-market teams make against older RMM platforms. Technician seats are not a separate line item. The meter runs on endpoints instead, so billing follows the size of the fleet and not the size of the help desk. Delivery is cloud, on usage-based terms.
Autotask PSA is the second-deepest PSA in the MSP market after ConnectWise Manage: strongest when the MSP runs Datto RMM and IT Glue, where the bidirectional integration creates an operations platform that competing stacks cannot match on data flow.
Scripting depth is the reason MSPs run ConnectWise Automate: complex automation across many client environments, maintained from one place. An extensive third-party integration set widens that reach. Patch management and remote monitoring fall under the same product. The same configuration depth works against smaller shops, which hit a real barrier with no dedicated platform administrator to own it.
ConnectWise Manage is the deepest PSA platform in the MSP market (service boards, agreement-based billing, procurement workflows, and project management that go beyond what any competitor offers), but the implementation timeline, UI age, and opaque pricing make it a commitment, not a subscription.
Now part of Kaseya's portfolio, Datto RMM gives MSPs scripted automation, patch management, and remote monitoring from a cloud-delivered console. Providers already using Datto backup and BCDR get native integration across that stack. Everyone else should judge the commercial model on its own merits, since pricing arrives by custom quote.
SMB and mid-market IT teams get remote access, endpoint patching and helpdesk ticketing in one purchase instead of three separate decisions, each with its own evaluation to run. Consolidated per-technician pricing often reads better than assembling the equivalent from point products, each carrying its own vendor and contract.
HaloPSA is the modern PSA platform that has emerged as the strongest alternative to ConnectWise Manage and Autotask for MSPs that want comparable feature depth with a cleaner UI, published pricing, and faster implementation.
Kaseya BMS is the PSA that comes free inside the Kaseya IT Complete bundle, covering standard ticketing, time tracking, and billing at no incremental cost for existing VSA customers, but with noticeably less depth than Autotask and ConnectWise Manage.
The commercial argument rests on integration: MSPs already using MSP360 Backup can tie endpoint monitoring and data protection together under a single vendor relationship. Teams judging RMM software on its own merits should put Atera and Syncro next to it before any decision gets made. Hosting is cloud, and pricing comes by custom quote.
N-able MSP Manager is a lightweight PSA built for small MSPs already running N-central or N-sight RMM. It handles ticketing, billing, and customer management without the cost or complexity of ConnectWise Manage or Autotask, but MSPs outgrowing it face a painful migration.
Sized for MSPs whose client base is both large and inconsistent, N-central reaches every machine in it, Windows, macOS and Linux alike, from one console. The scripting engine and policy-based automation framework reward technical depth on the MSP side. A smaller shop without a dedicated platform administrator will likely find more product here than it can put to work, and licensing is quoted.
Technicians get real-time alerting and remote remediation from their phones through the iOS and Android app, the clearest differentiator in Pulseway's RMM software. Small IT teams and MSPs whose engineers are rarely at a desk benefit most from that. Endpoint-based pricing stays predictable as device counts grow across a client base.
Ticketing, client management, remote monitoring and automation sit together in one modern interface aimed at smaller MSPs rather than enterprise service providers. Per-technician pricing covers both the PSA and the RMM side, and the commercial pitch is directed squarely at MSPs currently paying separately for ConnectWise or Kaseya equivalents.
Syncro sells both halves of an MSP stack, remote monitoring and professional services automation, for a single per-technician fee with no add-on modules stacked on top. MSPs that have accumulated separate per-product costs find one number easier to model, and below ten technicians it is frequently cheaper outright, which is why the pricing is the central commercial argument.
Common questions about MSP software for healthcare IT
What MSP software capabilities matter most for healthcare IT?
+
PHI encryption at rest and in transit, access controls that satisfy HIPAA's Security Rule, audit logging detailed enough for regulatory review, and support for the clinical device estate the team already runs.
Does MSP software need to be HIPAA certified?
+
There is no official HIPAA certification for software. What matters is whether the vendor signs a Business Associate Agreement, encrypts PHI, provides audit logging, and supports access controls that satisfy the HIPAA Security Rule.
How do healthcare organizations evaluate MSP software?
+
Start with whether a Business Associate Agreement is available, then work through data residency, network segmentation, compliance reporting depth, and whether the product can run inside restricted clinical network segments.